Divestment of Pharmadule Emtunga (SE) to 3i (UK) by Industrial Development & Investment AB (”IDI”) (SE) — Amount not disclosed.

Carnegie acted as adviser to IDI in the divestment of Pharmadule Emtunga, a world leading manufacturer of high technology facilities to primarily the pharmaceutical, biotech and offshore industries. IDI is an independent private equity company focusing on small to middle-sized companies in northern Europe. 3i invests in businesses across three continents through local investment teams in Europe, Asia Pacific and the USA. February, 2004.